Bio Science Adds Significant New Talent in Preparation for Building and Operation of the BioCenter.BALTIMORE--(HealthWire)--November 1, 1994--Bio Science Contract Production Limited Partnership today announced the recent addition of Edward M. Sybert as Vice President of Operations; and Drs. Howard L. Levine and Barry Aron as new members of its Scientific Advisory Board. Bio Science is the builder and operator of the BioCenter, a planned 54,000 square foot, $26.2 million GMP GMP (guanosine monophosphate): see guanine. biopharmaceutical production facility in Baltimore. "Bio Science is extremely fortunate to add such talented individuals to its team," said Jacques R. Rubin, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "As we gear up to build the BioCenter facility, their contributions will be instrumental in the creation of a state-of-the-art biopharmaceutical contract production facility in Baltimore, Maryland "Baltimore" redirects here. For the surrounding county, see Baltimore County, Maryland. For other uses, see Baltimore (disambiguation). Baltimore is an independent city located in the state of Maryland in the United States. ." Sybert brings over 20 years of design, construction, and management experience to Bio Science. During his career in the life sciences industry, Sybert designed and built fermentation pilot facilities for W.R. Grace & Co., IGENE Inc., and the Frederick Cancer Research Facility. In addition, he was responsible for building the Bioprocess bi·o·proc·ess n. 1. A technique that produces a biological material, such as a genetically engineered microbial strain, for commercial use. 2. Scale-up Facility for the University of Maryland University of Maryland can refer to:
Sybert commented, "I am delighted to be playing an integral role in Bio Science's vision of making a multi-user, biopharmaceutical GMP manufacturing facility available for biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. . The BioCenter is bound to attract many companies to Maryland to fulfill their production needs, as it can relieve the financing and staffing difficulties of building their own such facilities. Contract production at the BioCenter truly represents the next evolutionary step in the biotechnology industry." Dr. Levine, former vice president of Manufacturing Operations for Repligen Corp., has spent the last 15 years involved in process development, manufacturing and engineering for several biotechnology companies, including Xoma Corp., Amgen Inc., and Genentech Inc. During this time he directed the design, construction, and validation of several GMP manufacturing facilities. "I am very pleased to advise Bio Science in developing the BioCenter, which will help young companies progress from the R&D stage to manufacturing pharmaceutical-grade quantities of product for the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval process," said Dr. Levine. "Historically, this critical transition has hindered many biotechnology companies. By lowering the risk and cost associated with manufacturing biopharmaceuticals, the BioCenter may play a large role in bringing many life-saving drugs to market and improving the quality of life for the people waiting for these new therapeutics." Dr. Barry Aron, a urologist Urologist A physician who deals with the study and treatment of disorders of the urinary tract in women and the urogenital system in men. Mentioned in: Congenital Bladder Anomalies, Lithotripsy, Men's Health, Overactive Bladder urologist , is president of medical staff at Shady Grove Adventist Hospital Shady Grove Adventist Hospital, a not-for-profit acute care hospital located in Rockville, MD, opened its doors in 1979. Today, Shady Grove Adventist Hospital serves as a primary health care resource for more than 250,000 local residents. in Rockville, Md. He founded the only community-based renal transplant renal transplant Transplantation of a kidney from a living donor or cadaver to a recipient with ESRD Indications–children Congenital kidney/GU tract malformations–42%; focal segmental glomerulosclerosis-12% and others; 31% of children were ≤ age 5 program in Maryland. With a strong background in immunology from the New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the School of Medicine, he is now primarily active in clinical work. Dr. Aron stated, "I am hopeful that my physician's perceptions, as an end user of biopharmaceutical products, will provide an added perspective and some clinical input for Bio Science's Scientific Advisory Board." Bio Science management together with advisory board members have been involved in the development of 27 biotechnology production facilities. Other members of Bio Science's Scientific Advisory Boards include Dr. Donald E. Durham, Senior Research Microbiologist at W.R. Grace & Co.; Dr. Lance K. Gordon, President and CEO at Ora Vax Inc.; Dr. Aaron H. Heifetz, Manager of Mammalian Cell Research Department, W.R. Grace & Co.; and Dr. Antonio R. Moreira, Director of the Chemical and Biochemical Engineering Department at the University of Maryland, Baltimore University of Maryland, Baltimore, (also known as UMB) was founded in 1807. It is one of the oldest universities in the United States and comprises some of the oldest professional schools in the nation and world. County. Bio Science Contract Production Limited Partnership, is an affiliate of Bio Science Contract Production Corp., which designs and builds production facilities for the biotechnology industry. With a proven track record in building successful contract production facilities, Bio Science was selected to build and operate the BioCenter facility in Baltimore, which is expected to begin operation by 1996. The BioCenter is partially funded through $16.2 million in grants through the State of Maryland, $1.5 million in federal grants, use of the $500,000 site from the City of Baltimore, and $8 million in cash and other consideration from Bio Science Contract Production. CONTACT: Karen Keep Vice President, 410/563-9200 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion